American Association for the Study of Liver Diseases and Taiwan Association for the Study of the Liver Community Conversation: Hepatocellular Carcinoma Surveillance, Challenges, and Solutions

Description

This joint AASLD and the Taiwan Association for the Study of the Liver (TASL) session aims to: (1) continue the collaborative relationship between TASL and AASLD; (2) share experiences and contributions to HCC surveillance in Taiwan with AASLD members; (3) facilitate young investigators' communication with AASLD members to foster future collaboration; and (4) encourage TASL members to attend The Liver Meeting to learn from and connect with scholars from around the world.

Journey Maps

Presentations

9:45 AM - 9:50 AM
Nov 08 2025
Washington, D.C.

Overview of the Goal of the Symposium

CJ Liu, Moderator
Liver Cancer
9:50 AM - 10:05 AM
Nov 08 2025
Washington, D.C.

Discussion

Yujin Hoshida, MD, PhD, Moderator
Liver Cancer
10:05 AM - 10:15 AM
Nov 08 2025
Washington, D.C.

Hepatocellular Carcinoma Surveillance in Taiwan: Current Status

Mei-Hsuan Lee, Presenter
Liver Cancer
10:15 AM - 10:25 AM
Nov 08 2025
Washington, D.C.

Hepatocellular Carcinoma Surveillance in the United States: Current Status

Anjana Pillai, MD, FAASLD, Presenter
Liver Cancer
10:25 AM - 10:35 AM
Nov 08 2025
Washington, D.C.

Hepatocellular Carcinoma Surveillance in Taiwan: Challenges and Solutions

Tung-Hung Su, MD, PhD, Presenter
Liver Cancer
10:35 AM - 10:45 AM
Nov 08 2025
Washington, D.C.

Hepatocellular Carcinoma Surveillance in the United States: Challenges and Solutions

Neehar D. Parikh, MD, MS, FAASLD, Presenter
Liver Cancer

Objectives

  • Compare and contrast the current HCC surveillance strategies in Taiwan and the US, identifying differences in the approaches and underlying settings.
  • Assess the limitations, challenges, and unmet needs of current HCC surveillance strategies to achieve early HCC detection.
  • Describe newly emerging strategies and technologies for refining HCC surveillance to address current challenges.